Skip to main content

Advertisement

SpringerLink
Log in

Life support of artificial liver: development of a bioartificial liver to treat liver failure

  • Topics
  • HBP treatment using cell transplantation in the near future
  • Published:
Journal of Hepato-Biliary-Pancreatic Surgery

Abstract

In recent years there has been a particular focus on research regarding tissue engineering targeting the liver, especially in terms of what types of cells and extracellular matrices should be organized and in what type of environments to create an artificial liver, i.e., a life-saving organ. The ideal is to use healthy human liver cells as a source of cells for such research, but there is an extreme shortage of human-donor livers that can be used for cell isolation. Therefore, we are presently working on the differentiation of embryonic stem cells into liver cells as well as reversibly immortalized human liver cell lines that can be cultured in large quantities and at low cost. We are also working on the development of a bioartificial liver (BAL) using such cells as a source. Herein, we introduce our findings on the current status of BAL development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920–6.

    Article  PubMed  CAS  Google Scholar 

  2. Vacanti JP, Vacanti CA. The history and scope of tissue engineering. In: Lanza RP, Langer R, Vacanti J, editors. Principles of tissue engineering. San Diego: Academic Press; 2000. p. 3–7.

    Chapter  Google Scholar 

  3. Kobayashi N, Fujiwara T, Westerman KA, Inoue Y, Sakaguchi M, Noguchi H, et al. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science. 2000;287:1258–62.

    Article  PubMed  CAS  Google Scholar 

  4. Okitsu T, Kobayashi N, Jun HS, Shin S, Kim SJ, Han J, et al. Transplantation of reversibly immortalized insulin-secreting human hepatocytes controls diabetes in pancreatectomized pigs. Diabetes. 2004;53:105–12.

    Article  PubMed  CAS  Google Scholar 

  5. Totsugawa T, Yong C, Rivas-Carrillo JD, Soto-Gutierrez A, Navarro-Alvarez N, Noguchi H, et al. Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with tamoxifen-mediated self-recombination. J Hepatol. 2007;47:74–82.

    Article  PubMed  CAS  Google Scholar 

  6. Soto-Gutierrez A, Navarro-Alvarez N, Rivas-Carrillo JD, Chen Y, Yamatsuji T, Tanaka N, et al. Differentiation of human embryonic stem cells to hepatocytes using deleted variant of HGF and poly-amino-urethane-coated nonwoven polytetrafluoroethylene fabric. Cell Transplant. 2006;15:335–41.

    Article  PubMed  Google Scholar 

  7. Chen Y, Soto-Gutierrez A, Navarro-Alvarez N, Rivas-Carrillo JD, Yamatsuji T, Shirakawa Y, et al. Instant hepatic differentiation of human embryonic stem cells using activin A and a deleted variant of HGF. Cell Transplant. 2006;15:865–71.

    Article  PubMed  Google Scholar 

  8. Soto-Gutierrez A, Kobayashi N, Rivas-Carrillo JD, Navarro-Alvarez N, Zhao D, Okitsu T, et al. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol. 2006;24:1412–9.

    Article  PubMed  CAS  Google Scholar 

  9. Navarro-Alvarez N, Soto-Gutierrez A, Rivas-Carrillo JD, Fox IJ, Tanaka N, Kobayashi N. Stem cell-derived hepatocytes. Curr Opin Organ Transplant. 2006;11:659–664.

    Article  Google Scholar 

  10. Watanabe T, Shibata N, Westerman KA, Okitsu T, Allain JE, Sakaguchi M, et al. Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers. Transplantation. 2003;75:1873–80.

    Article  PubMed  CAS  Google Scholar 

  11. Noguchi H, Kobayashi N, Westerman KA, Sakaguchi M, Okitsu T, Totsugawa T, et al. Controlled expansion of human endothelial cell populations by Cre/loxP-based reversible immortalization. Hum Gene Ther. 2002;13:321–34.

    Article  PubMed  CAS  Google Scholar 

  12. Maruyama M, Kobayashi N, Westerman KA, Sakaguchi M, Allain JE, Totsugawa T, et al. Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT. Transplantation. 2004;77:446–51.

    Article  PubMed  CAS  Google Scholar 

  13. Matsumura T, Takesue M, Westerman KA, Okitsu T, Sakaguchi M, Fukazawa T, et al. Establishment of an immortalized human-liver endothelial cell line with SV40T and hTERT. Transplantation. 2004;77:1357–65.

    Article  PubMed  CAS  Google Scholar 

  14. Sternberg N, Hamilton D. Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J Mol Biol. 1981;150:467–86.

    Article  PubMed  CAS  Google Scholar 

  15. Narushima M, Kobayashi N, Okitsu T, Tanaka Y, Li SA, Chen Y. A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol. 2005;23:1274–82.

    Article  PubMed  CAS  Google Scholar 

  16. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–7.

    Article  PubMed  CAS  Google Scholar 

  17. Rambhatla L, Chiu CP, Kundu P, Peng Y, Carpenter MK. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant. 2003;12:1–11.

    Article  PubMed  Google Scholar 

  18. Xu C, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol. 2001;19:971–4.

    Article  PubMed  CAS  Google Scholar 

  19. Tanaka K, Kobayashi N, Soto-Gutierrez A, Rivas-Carrillo JD, Navarro-Alvarez N, Chen Y, et al. Prolonged survival of mice with acute liver failure with transplantation of monkey hepatocytes cultured with an antiapoptotic pentapeptide V5. Transplantation. 2006;81:427–37.

    Article  PubMed  CAS  Google Scholar 

  20. Ikeda H, Kobayashi N, Tanaka Y, Nakaji S, Yong C, Okitsu T, et al. A newly developed bioartificial pancreas successfully controls blood glucose in totally pancreatectomized diabetic pigs. Tissue Eng. 2006;12:1799–809.

    Article  PubMed  CAS  Google Scholar 

  21. Soto-Gutierrez A, Navarro-Alvarez N, Rivas-Carrillo JD, Tanaka K, Chen Y, Misawa H, et al. Construction and transplantation of an engineered hepatic tissue using a polyaminourethane-coated nonwoven polytetrafluoroethylene fabric. Transplantation. 2007;83:129–137.

    Article  PubMed  CAS  Google Scholar 

  22. Kobayashi N, Okitsu T, Nakaji S, Tanaka N. Hybrid bioartificial liver: establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use. J Artif Organs. 2003;6:236–44.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama, 700-8558, Japan

    Naoya Kobayashi

Authors
  1. Naoya Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naoya Kobayashi.

About this article

Cite this article

Kobayashi, N. Life support of artificial liver: development of a bioartificial liver to treat liver failure. J Hepatobiliary Pancreat Surg 16, 113–117 (2009). https://doi.org/10.1007/s00534-008-0022-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00534-008-0022-1

Keywords

Search

Navigation